NasdaqCM - Delayed Quote USD
Pulmatrix, Inc. (PULM)
At close: October 21 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -1.45 | -1.14 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | 2.2M | -- | 7.3M | 6.93M |
| Low Estimate | 1.77M | -- | 6.87M | 6.93M |
| High Estimate | 1.77M | -- | 6.87M | 6.93M |
| Year Ago Sales | 1.71M | -- | 6.07M | 7.3M |
| Sales Growth (year/est) | 28.90% | -- | 20.20% | -5.00% |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -1.51 | -1.44 | -1.23 | -1.05 |
| EPS Actual | -1.45 | -1.14 | -1.04 | -1.03 |
| Difference | 0.06 | 0.3 | 0.19 | 0.02 |
| Surprise % | 4.00% | 20.80% | 15.40% | 1.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
| 30 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
| 60 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
| 90 Days Ago | -1.04 | 0 | -4.34 | -4.5 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PULM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.60% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.87% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/7/2023 |
| Maintains | HC Wainwright & Co.: Buy | 3/30/2022 |
Related Tickers
LVTX LAVA Therapeutics N.V.
1.7206
+3.03%
SNPX Synaptogenix, Inc.
3.6000
+11.46%
TECX Tectonic Therapeutic, Inc.
36.90
-1.34%
PHIO Phio Pharmaceuticals Corp.
3.1800
+9.28%
HLVX HilleVax, Inc.
1.8300
-2.66%
ANTX AN2 Therapeutics, Inc.
1.0800
+2.86%
ATXI Avenue Therapeutics, Inc.
2.0000
-5.21%
HSTO Histogen Inc.
0.3000
+41.18%
BLPH Bellerophon Therapeutics, Inc.
0.0360
0.00%
DOMH Dominari Holdings Inc.
1.8200
+0.55%